Mainolfi Nello sold KYMR
July 7, 2026 · Form 4 insider transaction
Mainolfi Nello sold 50,000 shares of Kymera Therapeutics, Inc. at $119.00 per share, a transaction worth $5.95M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
50,000
Price
$119.00
Total value
$5.95M
InsiderMainolfi Nello
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 7, 2026
Filing dateJuly 7, 2026
Shares owned after666,568
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.